Origin: TB-500 is a shorter synthetic version of Thymosin Beta-4, which is a naturally occurring protein involved in tissue repair and regeneration.
Structure: It contains a key amino acid sequence (the actin-binding region) thought to drive many of its biological effects.
Wound healing: Early studies suggest it may speed up repair of skin, muscle, and other soft tissues.
Angiogenesis: It’s been shown in some animal models to promote new blood vessel formation.
Anti-inflammatory effects: May reduce inflammatory markers and improve tissue recovery.
Eye & heart research: Experimental use in corneal repair and cardiac tissue healing.
Sports medicine & performance: Anecdotally used for recovery from injury and training stress, though this is not an FDA-approved use.
Typically studied as a subcutaneous injection in research settings.
Dosage and cycles vary widely in anecdotal reports, but there is no standardized or FDA-approved protocol.
Human safety data is limited: Most findings come from animal studies.
Side effects: Reported risks include fatigue, headaches, nausea, and potential unknown long-term risks.
Regulation: Not FDA-approved for human use. It’s sold in research markets only, often labeled “not for human consumption.”
Origin: TB-500 is a shorter synthetic version of Thymosin Beta-4, which is a naturally occurring protein involved in tissue repair and regeneration.
Structure: It contains a key amino acid sequence (the actin-binding region) thought to drive many of its biological effects.
Wound healing: Early studies suggest it may speed up repair of skin, muscle, and other soft tissues.
Angiogenesis: It’s been shown in some animal models to promote new blood vessel formation.
Anti-inflammatory effects: May reduce inflammatory markers and improve tissue recovery.
Eye & heart research: Experimental use in corneal repair and cardiac tissue healing.
Sports medicine & performance: Anecdotally used for recovery from injury and training stress, though this is not an FDA-approved use.
Typically studied as a subcutaneous injection in research settings.
Dosage and cycles vary widely in anecdotal reports, but there is no standardized or FDA-approved protocol.
Human safety data is limited: Most findings come from animal studies.
Side effects: Reported risks include fatigue, headaches, nausea, and potential unknown long-term risks.
Regulation: Not FDA-approved for human use. It’s sold in research markets only, often labeled “not for human consumption.”
